baber/WOPTO huggingface dataset:
Patent CA-2120202-C (CA)
Inventor: ARABEYRE RENE
IPC: A61F13/08
Filed: 1994-03-29
Granted: 1998-02-03
Abstract: The invention relates to a medical compression device comprising a main part which is made of an elastic fabric and which serves to compress a leg or an arm in order to treat venous or lymphatic insufficiency. According to the invention, the main part (11; 16) is expediently continued via an elastic support band (20) consisting of an elastic braid or lace (21) covered, on the inner side, with a design (23) made of a nonslip material, the fibres constituting the braid or the lace of this band being chosen in such a way that the said band has at the same time a low elongation characteristic and exerts on the limb in question a pressure which is less than that exerted by the main part of the device in the vicinity of the said band. <IMAGE>
Patent CA-2122987-C (CA)
Title: Dye transfer inhibiting compositions
Inventor: BUSCH ALFRED
IPC: D06L4/40
Filed: 1992-10-28
Granted: 1998-01-27
Abstract: Dye transfer inhibiting compositions are disclosed, comprising an enzyme exhibiting peroxidase activity, a hydrogen peroxide or a hydrogen peroxide precursor or an enzymatic system capable of generating hydrogen peroxide, an additional oxidizable substrate, and a cellulase, characterized in that the cellulase provides at least 10 % removal of immobilized radioactive labelled carboxymethyl cellulose according to C14CMC method at 25 x 10-6 % by weight of the laundry test solution. According to the present invention, a preferred cellulase consists essentially of a homogeneous endoglucanase component which is immunoreactive with a monoclonal antibody raised against a partially purified = 43 kD cellulase derived from Humicola insolens:DM1800.
Patent CA-2125105-C (CA)
Title: Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
Inventor: LANG HANS-JOCHEN
IPC: C07D241/28
Filed: 1994-06-03
Granted: 2006-05-09
Abstract: There are described benzoylguanidines of the formula I (see formula I) where R(1) is H, Hal, -NO2, -C.ident.N, X o-(CH2)p-(CF2)q-CF3, R(5)-SO m, R(6)-CO- or R(6)R(7)N-SO2-, where X is O, S or NR(14), m is 0-2, o is 0 or 1, p is 0-2, q is 0-6, R(5) and R(6) are alk(en)yl, -C n H2n-R(8) or CF3, n is 0-4, R(8) is cycloalkyl or phenyl, where R(6) also has the meaning of H, R(2) is (see formula II) or (see formula III) or (see formula IV) where Y is O, -S- or -NR(12)-; R(11) and R(12) = H or alkyl, and h is zero or 1, and i, j and k are 0-4, but where h, i and k are not simultaneously zero, R(3) is defined as R(1), or is alkyl or -X-R(13) where X is O, S or NR(14), R(14) is H or alkyl, R(13) is H, (cyclo)alkyl or -C b H2b-R(15) where b is 0-4, R(15) is phenyl, R(4) is H, -OR(16) or -NR(16)R(17) where R(16) and R(17) are H or alkyl and their pharmaceutically tolerable salts.      They are obtained from a compound II    in which R(1) to R(4) have the given meaning and L is a leaving group which can be easily nucleophilically substituted by reaction with guanidine. The compounds, as antiarrhythmic pharmaceuticals having a cardioprotective component, are outstandingly suitable for infarct prophy-laxis and infarct treatment and for the treatment of angina pectoris, where they also preventively inhibit or greatly decrease the pathophysiological processes in the formation of ischemically induced damage, in particular in the production of ischemically induced cardiac arrhythmias.
Patent CA-2125175-C (CA)
Title: New peptide derivatives
Inventor: TEGER-NILSSON ANN-CATRINE ELIS
IPC: C12N15/00
Filed: 1992-12-01
Granted: 2001-09-11
Abstract: The invention relates to new competitive inhibitors of thrombin, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as anticoagulants for prophylaxis and treatment of thrombo-embolic diseases according to formula (I) wherein A represents a methylene group, an ethylene group or a propylene group, which may be substituted or A represents -CH2-O-CH2-, -CH2-S-CH2-, -CH2-SO-CH2-, or A represents -CH2-O-, -CH2-S-, -CH2-SO-, with the heteroatom functionality in position 4, or n is an integer 2 to 6; and B represents -N(R6)-C(NH)-NH2, wherein R6 is H or a methyl group, or B represents -S-C(NH)-NH2, or -C(NH)-NH2. Further described is new use in syn-thesis of pharmaceutical compounds of a compound of formula (II).
Patent CA-2130798-C (CA)
Title: Recovery of non-ferrous metals from dross
Inventor: GRIPENBERG HENRIK
IPC: F27D99/00
Filed: 1992-02-25
Granted: 1999-10-12
Abstract: The invention relates to a method for recovering non-ferrous metal from a dross starting material containing this metal, optionally together with non-ferrous metal scrap, and/or a starting material comprised of such scrap. The method comprises introducing the starting material into a rotary furnace or rotatable converter provided with a refractory lining, heating the starting material to a temperature above the melting point of the metal while rotating the furnace either continuously or intermittently, and removing the resultant molten metal from beneath the overlying dross residues. The method is characterized by heating the starting material in the absence of a protective salt layer with the aid of a so-called oxy-fuel-burner which is supplied with a fossil fuel and with a gas that contains at least 80 % oxygen, and by rotating the furnace at a speed of 5 r.p.m or lower.
Patent CA-2141866-C (CA)
Inventor: SAUTER ERICH W
IPC: B65B1/02
Filed: 1993-08-06
Granted: 2001-02-27
Abstract: Procédé et appareil d'encapsulation de petits articles tels que des médicaments de forme cylindrique ou des pastilles. Des demi-capsules de gélatine sont formées sur les pointes (11) de blocs (10) et sont renvoyées vers un poste où elles sont taillées à mesure et adaptées sur les extrémités opposées du produit à encapsuler. Les moitiés de capsules sont d'abord séchées jusqu'à avoir une humidité d'environ 20 % en poids puis elles sont adaptées par pression sur les extrémités des pastilles et on les laisse sécher afin d'obtenir un assemblage serré par rétrécissement qui rend pratiquement impossible l'enlèvement des couvertures de gélatine sans laisser de traces visibles de spoliation. Le produit fini présente une surface externe plus lisse qui se prête à l'impression.
Patent CA-2151499-C (CA)
Inventor: ABE TAKEO
IPC: A47C27/08
Filed: 1994-10-13
Granted: 1999-07-06
Abstract: This device has a cushion member adapted to be compressed resiliently under a load. A case is placed on an upper surface of this cushion member. This case has upper and lower surfaces, and is provided in the upper surface with an opened storage space. In this storage space, water bags made of flexible waterproof sheets in the form of a bag and containing water therein are provided. The cushion member and the case placed thereon are enclosed with an outer cover.
Patent CA-2153195-C (CA)
Title: New benzopyran derivatives; process for preparing the same and pharmaceutical compositions containing them
Inventor: LAVIELLE GILBERT
IPC: C07D491/052
Filed: 1995-07-04
Granted: 2004-06-15
Abstract: Benzopyran derivs. of formula (I), their isomers and acid addn. salts, are new. n = 1 or 2; R1 = H, 1-6C alkyl, benzyl, acetyl, benzoyl, allyl, pyridinecarbonyl, pyridine-methyl, pyridine-aminocarbonyl, phthalimido(1-6C)alkyl, (thiochroman-8-yl-oxy)-(1-4C)alkyl, (benzo-dioxanyl-oxy)(1-4C)alkyl, acylamino(1-6C)alkyl; acyl (in acylamino) = benzoyl, naphthylcarbonyl, thienylcarbonyl, (1-6C)alkyl-carbonyl, furylcarbonyl, pyrrolylcarbonyl, pyridinylcarbonyl or (3-7C)cycloalkylcarbonyl, all opt. substd. by one or more halo, trihalomethyl, alkoxy or hydroxy; R2, R3, R4 = H, halo, (1-6C)alkyl, (1-6C)alkoxy, hydroxy, acetyl, aminocarbonyl, aminomethyl, cyano, nitro, amino; phenyl opt. substd. by one or more halo, hydroxy, (1-6C)alkoxy, (1-6C)alkyl or trihalomethyl; furyl, pyridinyl, thienyl or pyrrolyl; or R2+R3 on adjacent C atoms form furan or phenyl.
Patent CA-2155182-C (CA)
Inventor: NAKAMURA JUNJI
IPC: G01N33/74
Filed: 1994-05-13
Granted: 2004-02-24
Abstract: This invention relates to an examination method of hormone-dependent tumors, more particularly to the method for the examination of hormone dependent tumors by culture of tumor tissue in (a) control culture medium without additive, (b) the culture medium with added a hormone synthetase substrate, and (c) the culture medium with added a hormone synthetase substrate and a hormone synthetase inhibitor and determination of relative growth ratios of tumor cells of (i) (b) to (a) and (ii) (c) to (a) for the judgment of the hormone-dependent tumor.        This invention provides simultaneous and easy examination of hormone dependent tumors and hormone synthetic enzymes.        Further this invention can be used for the new classification of tumors and indications of medical treatment for the cancer patients.
Patent CA-2155912-C (CA)
Inventor: CALKINS DENNIS EARL
IPC: E21B33/043
Filed: 1995-08-11
Granted: 1999-10-19
Abstract: A  fixed,  non-compliant,  non-floating  offshore  platform subject to lower wave, wind, current, and rig loadings resulting from a configuration that supports the portion of the well casings that extend from near the seafloor to a deck level above the water surface using tension instead of intermediate lateral supports.  Only the smallest one or two well casings among all those that comprise the well casing system are extended back from the seafloor, which further reduces the lateral loadings on the structure.
Patent CA-2157927-C (CA)
Inventor: LITTLE ROGER G II
IPC: C07K14/47
Filed: 1994-03-11
Granted: 1999-03-30
Abstract: Procédés thérapeutiques pour le traitement de pathologies telles que la neutralisation de l'activité anticoagulante de l'héparine, l'inhibition de l'angiogenèse, la prolifération de cellules tumorales et endothéliales, et pour le traitement des maladies inflammatoires chroniques, par administration de produits protéiques augmentant le pouvoir bactéricide et/ou la perméabilité.
Patent CA-2161223-C (CA)
Inventor: TANAKA HIROKAZU
IPC: B23K26/382
Filed: 1994-04-22
Granted: 2000-05-16
Abstract: Objective:  To provide a mesh made out of an unlimited number of materials, and in particular which is made out of a material which has superior resistance to corrosion and chemicals yet is safe for humans, and to provide a mesh comprising holes whose shape and cross-sectional contour can be selected as needed.            Configuration:  An excimer laser beam L projected by laser oscillator 12 is shaped by being directed through a number of openings 2 in mask 1.  The shaped beams pass through an optical system containing object lens 3 and are projected onto material 5, a thin piece of a polymer such as polysulf-one or polyester, which is fixed on work stage 4.  The image of the pattern formed by openings 2 is made to appear, and a number of holes 6 are created in material 5 to produce a thin mesh 7 suitable for use in an inhaler or a similar device.
Patent CA-2161852-C (CA)
Title: Privacy inserts for chain link fences having overlapping portions
Inventor: MEGLINO DON A
IPC: E04H17/06
Filed: 1995-10-31
Granted: 2003-08-05
Abstract: Privacy slats for chain link fences and a system comprising a chain link fence and a plurality of slats wherein portions of slats which are positioned substantially parallel are disposed in overlapping arrangement.   One embodiment comprises a plurality of slats having a central, substantially tubular section with opposing wings positioned in an offset manner such that the wing on one side of the central tubular portion is disposed more forwardly of the wing on the opposing side of the central tubular portion.
Patent CA-2164974-C (CA)
Title: Catalytic distillation structure
Inventor: JOHNSON KENNETH H
IPC: B01J12/00
Filed: 1994-05-19
Granted: 2005-11-08
Abstract: A catalytic distillation structure (10) having a plurality of corrugated vertically disposed catalyst containing elements (12) separated by inert spacing elements (24) is disclosed. The catalyst containing elements (12) each have two layers of gas permeable material (18, 20), such as wire mesh, joined together at regularly spaced intervals (13) to form a single sheet (12) having pockets (22) disposed on the surface. A particulate catalyst (26) is disposed within the pockets (22). The catalyst (26) within the pockets (22) provides a reaction zone where catalytic reactions may occur and the gas permeable sheets (18, 22) provide mass transfer surfaces to effect a fractional distillation. The spacing elements (14) allow for a variation of the catalyst density and loading.
Patent CA-2166898-C (CA)
Title: Novel structural analogues of vitamin d
Inventor: BOUILLON ROGER
IPC: C07C47/192
Filed: 1994-07-07
Granted: 2004-09-07
Abstract: The present invention relates to analogues of vitamin D, which lack the combined presence of the trans-fused six-membered C-ring and of five-membered D-ring, but still possess a central part consisting of a subsituted chain of five atoms, atoms which correspond to positions 8, 14, 13 17 and 20 of vitamin D, and at the ends of which are connected, at position 20 a structural moiety representing part of the side chain of vitamin D or of an analogue of vitamin D, and at positi on 8 the .DELTA.(5,7)-diene moiety connected to the A-ring of the active 1-alpha-hydroxy metabolite or of an established vitamin D analogue, t o their preparation process, to preparation intermediates, to pharmaceutical preparations comprising these compounds and to their use in medicine.
Patent CA-2170739-C (CA)
Inventor: HERMENS WILLEM THEODOOR
IPC: A61K38/54
Filed: 1994-08-31
Granted: 2007-04-10
Abstract: A therapeutic or prophylactic treatment method of acute myocardial infarctio n, comprising administering exogenous C1-esterase inhibitor, alone or in combination with other drugs, to a patient with acute myocardial infarction or to a patient at risk for acute myocardial infarction. The treatment inhibits the inflammatory reaction, more specifically the activation of the complement system, which occurs in the course of acute myocardial infarction. The C1-esterase inhibitor may include C1-esterase inhibitor purified from plasma or other biological materials, or recombinant C1-esterase inhibitor or recombinant variants derived therefrom, or recombinant constructs of other inhibitors having a specificity similar to C1-esterase inhibitor.
Patent CA-2183367-C (CA)
Inventor: MAURIN FLORENCE
IPC: A61K9/00
Filed: 1996-08-14
Granted: 2005-05-10
Abstract: Ready-to-use eye lotions are aq. solns. contg. indomethacin (I) and the 1-4C alkyl or hydroxyalkyl ethers of  beta - or  gamma -cyclodextrin (II) derivs., present in a (II):(I) molar ratio of at least 10:1 and a pH of 4-6. (II) is pref. hydroxypropyl- beta -cyclodextrin with a degree of substitution of 0.4. The pH is pref. 4.5-5.5.
Patent CA-2184850-C (CA)
Inventor: NAZMY MOHAMED
IPC: C22F1/10
Filed: 1996-09-05
Granted: 2008-04-29
Abstract: The process serves for the production of a body of material stable at high temperatures. In this process, the body of material is formed by solution annealing and subsequent precipitation hardening of a hot work-hardened starting body composed of an iron--nickel superalloy of the type IN 706 provided in a furnace. The body of material is distinguished by a particularly high ductility in combination with high hot strength if the solution-annealed starting body is cooled from the annealing temperature envisaged for the solution annealing to the temperature envisaged for the precipitation hardening at a cooling rate of between 0.5 and 20 [°C/min].
Patent CA-2187512-C (CA)
Title: Process for producing a graduated coating of calcium phosphate phases and metallic oxide phases on metal implants
Inventor: SCHARNWEBER DIETER
IPC: C25D9/04
Filed: 1996-02-06
Granted: 2007-05-29
Abstract: The invention concerns a process for producing a gradient coating of calcium phosphate phases and metal oxide phases on metallic implants, in particular made of titanium or titanium alloys, for use as dental, jaw or joint implants. A solution containing calcium ions and phos-phate ions is used as an electrolyte the pH value of which is slightly acidic to approximately neutral. The substrate electrodes are alternately polarized to be cathodic or anodic. The depos-ited layer forms a gradient coating, which is strongly adherent, has a fine structure and is dis-tinguished for its high degree of biocompatibility.
Patent CA-2195747-C (CA)
Title: New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
Inventor: HAMORI TAMAS
IPC: C07D491/04
Filed: 1995-07-28
Granted: 2006-01-24
Abstract: New 3-substituted 3H-2,3-benzodiazepine derivatives of general formula I (see formula I) in which R1, R2, R3, R4, R5, R6, R7 and n have the meanings indicated in the description, their production as well as their use as pharmaceutical agents are described.
Patent CA-2198111-C (CA)
Inventor: PHILLIPS JAMES PATRICK
IPC: H01Q21/24
Filed: 1996-04-26
Granted: 2000-01-11
Abstract: The present invention provides a method (400) and antenna (100) for providing an omnidirectional pattern. The antenna (100) is smaller than prior art omnidirectional antennas with the same bandwidth. The smaller size is made possible by the use of at least one capacitive element (104) at a discontinuity in the loop (102). The pattern is balanced and therefore the omnidirectionality is maintained by the current maximum (110 and 112) that are created by the capacitive element (104).
Patent CA-2203766-C (CA)
Inventor: ERHARD HELMUT
IPC: B41F17/00
Filed: 1995-10-19
Granted: 2005-07-05
Abstract: Dispositif d'impression pour l'impression de supports plats d'impression individuels, de préférence, pour l'impression en couleurs de disques compacts. Un ensemble de groupes d'impression (6, 7, 8, 9) est disposé dans un cadre commun. Les distances (a) entre les points d'impression de groupes d'impression immédiatement voisins sont supérieures à la longueur ou au diamètre (b) du support d'impression.
Patent CA-2205215-C (CA)
Inventor: MANN STEVEN W
IPC: F16L3/10
Filed: 1997-05-12
Granted: 2005-07-12
Abstract: A clamp for a line includes a body having a first portion for engaging the line and a keeper having a second portion for engaging the line. A pivoting assembly is coupled to the body and the keeper for pivotally coupling the keeper and the body, and includes a shaft and a shaft support pivotally receiving the shaft. The shaft has a longitudinal axis and pivots about the longitudinal axis. The clamp also includes a torsional spring coupled to the pivoting assembly for biasing the keeper second portion away from the body first portion. Further, the clamp includes a control device in the form of U-bolts, coupled to the body and the keeper, for controlling the angular position of the keeper relative to the body.
Patent CA-2205659-C (CA)
Title: Coating of wax-like materials onto moving strip articles
Inventor: INNES ROBERT A
IPC: B05D7/14
Filed: 1995-11-23
Granted: 2001-01-23
Abstract: A process of coating a heat-conductive strip article, e.g. aluminum or aluminum alloy strip (14) used in the automotive industry, with a solid wax-like coating material, preferably a wax-type lubricant. The process involves heating a solid wax-like coating material that melts in a temperature range of about 30 to 100 ~C to form a melt having a viscosity in a range of about 50 centipoise or less and flowing the melt onto a moving surface of the strip article through an elongated slot (15) in a movable coating head having an extended surface adjacent to the slot to form a coating layer on the article.  The coating head is pushed towards the surface of the strip article as the melt is flowed as a coating onto the surface from the slot (15) to reduce a coating thickness by pressing the extended surface of the coating head onto the coating as the coating is formed. The process allows a coating of a wax-like material to be formed to a desired thickness and yet allows the wax-like material to solidify shortly after application to the strip article (14) so that the strip can be coiled without providing a cooling run of undue length or special cooling devices.
Patent CA-2210085-C (CA)
Inventor: HUSTON ALAN L
IPC: A61N5/10
Filed: 1995-07-20
Granted: 2004-03-23
Abstract: A thermoluminescent radiation dosimeter system for the remote monitoring of radiation sources is disclosed. The system includes a radiation-sensitive thermoluminescent dosimeter (17) which utilizes a new, semiconductor-doped glass material disposed at a remote location for storing energy from ionizing radiation when exposed thereto and for releasing the stored energy in the form of thermoluminescence light at a first wavelength when stimulated by exposure to light energy at a predetermined stimulating second wavelength. The system further includes: an optical source (21) for providing stimulating light energy at the predetermined stimulating second wavelength; a thermoluminescence detector (33) for measuring thermoluminescent emissions; and an optical fiber (27) for passing the predetermined stimulating light energy from the optical source (21) to the thermoluminesce nt dosimeter (17) to stimulate the thermoluminescent dosimeter to produce thermoluminescence light from stored energy and for passing the thermoluminescence light to the thermoluminescence detector (33) to enable the thermoluminescence detector to measure any thermoluminescent emissions occurring when the thermoluminescent dosimeter is heated by the light energy at the predetermined stimulating second wavelength.
Patent CA-2210544-C (CA)
Inventor: CANOVA ANTONIO
IPC: H01F27/28
Filed: 1997-07-16
Granted: 2002-01-29
Abstract: The  low-profile  magnetic  device  comprises  at least one winding  formed by a plurality  of  conductive metal  laminations  (9)  of substantially annular  layout, superposed and electrically insulated from each other and with respect to the ferromagnetic core and furnished with appendages (9X)  for external connection. The laminations are  accommodated  in  a  well   (7A)   produced  in  an electrically insulating container  (7)  inserted into the said ferromagnetic core (1A, 1B) and a sheet of insulating material  (11)  is disposed between adjacent laminations. Each of the said laminations (9)  is furnished, along at least one of its edges, with a plurality of protuberances (9A,  9B,  9C)  disposed in such a way that  on mutually superposing identical laminations rotated by 180° one with respect to another about a mid-line  (M-M)  lying in the plane  of  the  lamination,  the  protuberances  of  one lamination (9)  are angularly offset with respect to the protuberances of the adjacent laminations.
Patent CA-2213096-C (CA)
Inventor: VAN OORSCHOT PAUL C
IPC: H04L9/30
Filed: 1997-08-14
Granted: 2000-10-31
Abstract: The invention allows for transporting, in different degrees of security strength, a symmetric key encrypted using an asymmetric encryption technique, and along with this transporting ciphertext derived from plaintext encrypted under this symmetric key. The encryptor encrypts the plaintext using a symmetric whose strength is commensurate with the trust level of the environment in which the encryptor is located. The encryptor encrypts this symmetric key for one or more intended recipients using an asymmetric technique commensurate with a high-trust environment. In the case of the encryptor residing in the low-trust environment, additionally encrypts this symmetric key using an asymmetric encryption public key of the originator itself (or alternatively, that of a third party). Decryption equipment in all environments uses the decryption process corresponding to an algorithm identifier included by the originator. In all cases, the asymmetric encryption/decryption process used for each specific recipient is of a strength commensurate with the trust level of that recipient's own environment.